Johnson & Johnson (NYSE:JNJ) subsidiary Biosense Webster said today that it acquired Coherex Medical for an undisclosed amount. Salt Lake City-based Coherex makes the Wavecrest anti-stroke device, which is designed to occlude the heart’s left atrial appendage to prevent blood clots from forming that could cause stroke. “The addition of the Coherex WaveCrest system complements […]
HRS2014: Devices combat drugs for treatment of AF stroke-risk patients
New clinical data continues to suggest that left atrial appendage occlusion devices may pose an improvement over warfarin drug regimens for treating patients at increased risk of stroke, researchers reported today.
TCT 2013: Docs trade barbs over LAA closure
St. Jude Medical’s Amulet LAA occluder
